Keith Javery, DO
Interventional Pain Medicine · Grand Rapids, MINPI 1891892402
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,868 of the $3,327 with a category attached, or 86.2%. 13 manufacturers reported payments, led by Abbott at 49.1% of the total.
Across 69 payments — averaging $48.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$2K
- Boston Scientific$434
- Spinefrontier, Inc.$286
- Spinal Simplicity, LLC$273
- Si-bone, Inc.$174
- Curonix LLC$162
- plus $362 from 7 others
What the payments were for
- Travel & lodging$42313%
- Food & beverage$2,86886%
- Education$361%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 30 | $1,635 |
| Boston Scientific | 5 | $434 |
| Spinefrontier, Inc. | 2 | $286 |
| Spinal Simplicity, LLC | 16 | $273 |
| Si-bone, Inc. | 2 | $174 |
| Curonix LLC | 4 | $162 |
| Medtronic(2 entities) | 3 | $107 |
| SPR Therapeutics, Inc | 1 | $103 |
| Stryker | 1 | $57 |
| Nalu Medical, Inc. | 2 | $37 |
| Nevro Corp. | 1 | $26 |
| Biodelivery Sciences International, Inc. | 1 | $17 |
| Avanos Medical | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PROCLAIM$456
- ETERNA$373
- Proclaim Family of SCS IPGs$280
- Superion Indirect Decompression System$232
- InSpan$191
- SIJFuse$191
- FacetFuse$191
- NanoFuse$191
- SPRINT PNS System$103
How this compares
$3,327 in reported general payments places this provider in the 65th percentile of 88 interventional pain medicine providers in Michigan.
See all interventional pain medicine providers in Michigan →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine Hcl | 54 | $1,722 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 101 | $1,696 |
| Celecoxib | 63 | $1,134 |
| Tizanidine Hcl | 157 | $959 |
| Duloxetine Hcl | 74 | $903 |
| Gabapentin | 45 | $730 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 34 | $713 |
| Methocarbamol | 70 | $661 |
| Baclofen | 51 | $634 |
| Cyclobenzaprine Hcl | 103 | $514 |
| Nabumetone | 18 | $414 |
| Ibuprofen | 34 | $381 |
| Lidocaine-PrilocaineLidocaine/Prilocaine | 19 | $320 |
| Amitriptyline Hcl | 19 | $304 |
| Meloxicam | 62 | $296 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in Grand Rapids
- Mary LeemputteGrand Rapids$8K
- Marc KornGrand Rapids$3K
- Stephen WinstonGrand Rapids$2K
- Scott GreenwaldGrand Rapids$2K
- Daniel MankoffGrand Rapids$1K
- Bennett WillardGrand Rapids$1K
- Ryan PollinaSaint Clair Shores$144K
- Ariel MajjhooMonroe$124K
- Chad BrummettAnn Arbor$109K
- Anand ThakurClinton Township$102K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.